[go: up one dir, main page]

BR9708468A - Tratamento de fotoferese de leucocitos. - Google Patents

Tratamento de fotoferese de leucocitos.

Info

Publication number
BR9708468A
BR9708468A BR9708468-9A BR9708468A BR9708468A BR 9708468 A BR9708468 A BR 9708468A BR 9708468 A BR9708468 A BR 9708468A BR 9708468 A BR9708468 A BR 9708468A
Authority
BR
Brazil
Prior art keywords
treatment
photopheresis
leukocyte
patient
blood
Prior art date
Application number
BR9708468-9A
Other languages
English (en)
Inventor
Susan N Mclaughlin
Bruce C Stouch
Jerome B Zeldis
Original Assignee
Therakos Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therakos Inc filed Critical Therakos Inc
Publication of BR9708468A publication Critical patent/BR9708468A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0066—Psoralene-activated UV-A photochemotherapy (PUVA-therapy), e.g. for treatment of psoriasis or eczema, extracorporeal photopheresis with psoralens or fucocoumarins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2103/05—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: <B>"TRATAMENTO DE FOTOFERESE DE LEUCóCITOS"<D>. é revelado um processo para tratar infecções de células sang³íneas mononucleares, que não infecções retroviróticas. é também um processo para modular a função de monócitos. O processo envolve o tratamento do sangue do paciente com um composto fotoativável seguido por ativação de luz ultravioleta do composto fotoativável. O sangue tratado como tal é retornado para o paciente em um processo conhecido como fotoferese extracorpórea. A função do monócito é modulada por este tratamento.
BR9708468-9A 1996-03-29 1997-03-26 Tratamento de fotoferese de leucocitos. BR9708468A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1426996P 1996-03-29 1996-03-29
US2989396P 1996-11-08 1996-11-08
PCT/US1997/004772 WO1997036581A1 (en) 1996-03-29 1997-03-26 Photopheresis treatment of leukocytes

Publications (1)

Publication Number Publication Date
BR9708468A true BR9708468A (pt) 2000-01-04

Family

ID=26685876

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9708468-9A BR9708468A (pt) 1996-03-29 1997-03-26 Tratamento de fotoferese de leucocitos.

Country Status (11)

Country Link
US (1) US5984887A (pt)
EP (1) EP0935462B1 (pt)
JP (1) JP2000510101A (pt)
CN (1) CN1121217C (pt)
AT (1) ATE300298T1 (pt)
AU (1) AU710242B2 (pt)
BR (1) BR9708468A (pt)
CA (1) CA2250919C (pt)
DE (1) DE69733826T2 (pt)
IL (1) IL126366A (pt)
WO (1) WO1997036581A1 (pt)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL126365A0 (en) * 1996-03-29 1999-05-09 Therakos Inc Photopheresis treatment of chronic hcv infections
NZ524459A (en) * 1997-07-10 2004-11-26 Therakos Inc Use of psoralen in the treatment of inflammatory disorders of the bowel and urinary bladder
WO1999028315A1 (en) 1997-11-28 1999-06-10 Lg Chemical Ltd. Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof
US7611831B2 (en) 1998-01-06 2009-11-03 Cerus Corporation Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrix
US7049110B2 (en) 1998-07-21 2006-05-23 Gambro, Inc. Inactivation of West Nile virus and malaria using photosensitizers
US7498156B2 (en) 1998-07-21 2009-03-03 Caridianbct Biotechnologies, Llc Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
US6219584B1 (en) 1999-07-09 2001-04-17 Therakos, Inc. Method and system for determining an effective amount of light energy to delivery to fluids having targets for the light energy
US7094378B1 (en) 2000-06-15 2006-08-22 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US7220747B2 (en) 1999-07-20 2007-05-22 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
US6495366B1 (en) 1999-09-03 2002-12-17 Therakos, Inc. Uninterrupted flow pump apparatus and method
US8722422B2 (en) 1999-09-03 2014-05-13 Therakos, Inc. Uninterrupted flow pump apparatus and method
ES2234668T3 (es) * 1999-10-05 2005-07-01 Universite De Montreal Derivados de rodamina para diagnostico y tratamiento fotodinamico.
WO2001080939A2 (en) * 2000-04-19 2001-11-01 Clemson University Uvc radiation therapy for chronic lymphocytic leukemia
US6970740B2 (en) * 2000-04-19 2005-11-29 Clemson University UVC rediation therapy for leukemia
US6793643B1 (en) 2000-04-21 2004-09-21 Therakos, Inc. Low extracorporeal volume treatment system
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
EP1990055A3 (en) 2001-11-29 2011-11-16 Therakos, Inc. Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells
US7479123B2 (en) 2002-03-04 2009-01-20 Therakos, Inc. Method for collecting a desired blood component and performing a photopheresis treatment
US7186230B2 (en) 2002-03-04 2007-03-06 Therakos, Inc Method and apparatus for the continuous separation of biological fluids into components
US20040127840A1 (en) 2002-03-04 2004-07-01 Steve Gara Blood separation apparatus and method of using the same
US7211037B2 (en) 2002-03-04 2007-05-01 Therakos, Inc. Apparatus for the continuous separation of biological fluids into components and method of using same
CA2377442A1 (en) * 2002-03-20 2003-09-20 Thomas Ichim Increasing tumor oxygen content by administration of stressed cells
US20070098686A1 (en) 2005-11-02 2007-05-03 David Peritt Use of apoptotic cells ex vivo to generate regulatory T Cells
JP5295950B2 (ja) 2006-05-02 2013-09-18 セラコス・インコーポレイテッド 移植片対宿主病または移植関連死に対する感受性を検出するための方法および試薬
MX2008014111A (es) * 2006-05-03 2009-03-06 Therakos Inc Metodos para tratar enfermedades qie implican enfermedades y condiciones relacionadas con estres.
EP2124771A4 (en) * 2007-03-01 2012-03-14 Nanospectra Biosciences Inc DEVICES AND METHODS FOR EXTRACORPORAL ABLATION OF CIRCULATING CELLS
US9358292B2 (en) 2007-04-08 2016-06-07 Immunolight, Llc Methods and systems for treating cell proliferation disorders
US9439897B2 (en) 2007-11-06 2016-09-13 Immunolight, Llc Use of psoralen derivatives and combination therapy for treatment of cell proliferation disorders
CN102056625B (zh) 2008-04-04 2015-11-25 免疫之光有限责任公司 用于原位光生物调节的非侵入性系统和方法
US20100210989A1 (en) 2008-12-23 2010-08-19 Janet Lesley Macpherson Processing blood
AR076361A1 (es) 2009-04-21 2011-06-08 Immunoligtht Llc Composicion farmaceutica. kit. metodos y sistemas de conversion ascendente de energia no invasivos para la fotobiomodulacion in-situ
US9399093B2 (en) 2012-01-27 2016-07-26 Fenwal, Inc. Systems and methods for performing online extracorporeal photopheresis
US20130252227A1 (en) 2012-03-20 2013-09-26 Fenwal, Inc. Apparatus and Method for Providing Cryopreserved ECP-Treated Mononuclear Cells
US11571504B2 (en) 2019-03-21 2023-02-07 Fenwal, Inc. Apparatus and method for batch photoactivation of mononuclear cells
US20150071935A1 (en) * 2012-05-27 2015-03-12 Marv Enterprises, LLC Treatment for the rapid amelioration of clinical depression
WO2014123521A1 (en) * 2013-02-06 2014-08-14 Fenwal, Inc. Method for delivering desired light dose to cells in a light attenuating medium
US10172995B2 (en) 2013-02-06 2019-01-08 Fenwal, Inc. System and method for determining irradiation exposure time with irradiation sensors during extracorporeal photopheresis
EP3838904A1 (en) 2014-06-19 2021-06-23 Immunolight, LLC Methods and systems for treating cell proliferation disorders with psoralen derivatives
US9208296B1 (en) 2014-06-19 2015-12-08 Norman Romanick Prevention of use of a contaminated medical product
WO2016115225A1 (en) 2015-01-14 2016-07-21 Immunolight, Llc. Non-invasive systems and methods for treatment of a host carrying a virus with photoactivatable drugs
US10434240B2 (en) 2015-08-17 2019-10-08 Fenwal, Inc. Methods and systems for processing and washing a photopheresis mononuclear cell product
EP3372259B1 (en) 2017-03-07 2022-11-23 Fenwal, Inc. System and methods for separating blood under conditions of reduced plasma clarity
US20190099610A1 (en) * 2017-10-04 2019-04-04 Hyper Light Technologies, Llc Cancer cell treatment
US11318239B2 (en) 2018-03-01 2022-05-03 Fenwal, Inc. Systems and methods for performing online extracorporeal photopheresis
AU2019266347B2 (en) 2018-05-11 2024-05-02 Lupagen, Inc. Systems and methods for closed loop, real-time modifications of patient cells
IL293773A (en) 2019-12-20 2022-08-01 Mallinckrodt Pharmaceuticals Ireland Ltd A method for generating immune cells in a blood-derived sample
TW202434278A (zh) 2022-12-21 2024-09-01 愛爾蘭商馬林克羅製藥愛爾蘭有限公司 用於免疫檢查點抑制劑之免疫相關不良事件之單獨脂聯素或與體外光照治療(ecp)組合
EP4389122A1 (en) 2022-12-21 2024-06-26 Mallinckrodt Pharmaceuticals Ireland Limited Adiponectin alone or in combination with extracorporeal photopheresis (ecp) for immune related adverse events of immune checkpoint inhibitors

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US298279A (en) 1884-05-06 Edwaed w
US299953A (en) 1884-06-10 Ealph bbownson
US298567A (en) 1884-05-13 Claek fishes
US549030A (en) * 1895-10-29 Vehicle-spring
US4196281A (en) * 1976-10-20 1980-04-01 Regents Of The University Of California Psoralens
IT1088554B (it) * 1977-11-17 1985-06-10 F I D I A Spa Procedimento sellettivo per la preparazione di derivati della 7-indrossi cumarina
US4398906A (en) * 1979-12-11 1983-08-16 Frederic A. Bourke, Jr. Method for externally treating the blood
US4321919A (en) * 1979-12-11 1982-03-30 Leukocyte Research, Inc. Method and system for externally treating human blood
US4428744A (en) * 1979-12-11 1984-01-31 Frederic A. Bourke, Jr. Method and system for externally treating the blood
US4464166A (en) * 1981-06-12 1984-08-07 Frederic A. Bourke, Jr. Method for externally treating the blood
US4612007A (en) * 1981-06-16 1986-09-16 Edelson Richard Leslie Method and system for externally treating the blood
FR2521999B1 (fr) * 1982-02-25 1984-05-25 Inst Nat Sante Rech Med Pyrido (3',4' : 4,5) furo (3,2-g) coumarines ou pyrido (3,4-h) psoralenes, obtention, applications en cosmetologie et a titre de medicaments, et compositions cosmetiques et pharmaceutiques les contenant
FR2521998B1 (fr) * 1982-02-25 1985-10-25 Inst Nat Sante Rech Med Pyrido (3,4-c) psoralenes, obtention, applications en cosmetologie et a titre de medicaments et compositions cosmetiques et pharmaceutiques les contenant
US4613322A (en) * 1982-12-08 1986-09-23 Edelson Richard Leslie Method and system for externally treating the blood
US4684521A (en) * 1982-12-08 1987-08-04 Frederic A. Bourke, Jr. Method and system for externally treating the blood
US4683889A (en) * 1983-03-29 1987-08-04 Frederic A. Bourke, Jr. Method and system for externally treating the blood
US4748120A (en) * 1983-05-02 1988-05-31 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US5176921A (en) * 1983-05-02 1993-01-05 Diamond Scientific Co. Method of blood component decontamination by glucose addition
US4727027A (en) * 1983-05-02 1988-02-23 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US4693981A (en) * 1983-12-20 1987-09-15 Advanced Genetics Research Institute Preparation of inactivated viral vaccines
US4681568A (en) * 1984-10-29 1987-07-21 Mcneilab, Inc. Valve apparatus for photoactivation patient treatment system
US4705498A (en) * 1984-10-29 1987-11-10 Mcneilab, Inc. Disposable temperature probe for photoactivation patient treatment system
US4568328A (en) * 1984-10-29 1986-02-04 Extracorporeal Medical Specialties, Inc. Automated photophoresis blood portion control methods and apparatus
US4623328A (en) * 1984-10-29 1986-11-18 Mcneilab, Inc. Pump monitor for photoactivation patient treatment system
US4737140A (en) * 1984-10-29 1988-04-12 Mcneilab, Inc. Irradiation chamber for photoactivation patient treatment system
US4573962A (en) * 1984-10-29 1986-03-04 Extracorporeal Medical Specialties, Inc. Cassette drawer assembly for photoactivation patient treatment system
US4573960A (en) * 1984-10-29 1986-03-04 Extracorporeal Medical Specialties, Inc. Three phase irradiation treatment process
US4643710A (en) * 1984-10-29 1987-02-17 Mcneilab, Inc. Valve apparatus for photoactivation patient treatment system
US4578056A (en) * 1984-10-29 1986-03-25 Extracorporeal Medical Specialties, Inc. Patient photopheresis treatment apparatus and method
US4596547A (en) * 1984-10-29 1986-06-24 Mcneilab, Inc. Valve apparatus for photoactivation patient treatment system
US4573961A (en) * 1984-10-29 1986-03-04 Extracorporeal Medical Specialties, Inc. Electronic control methods for puvapheresis apparatus
US4687464A (en) * 1984-10-29 1987-08-18 Mcneilab, Inc. Zero insertion force socket for photoactivation patient treatment system
US4708715A (en) * 1984-10-29 1987-11-24 Mcneilab, Inc. Light array assembly for photoactivation patient treatment system
US4692138A (en) * 1984-10-29 1987-09-08 Mcneilab, Inc. Pump block for interfacing irradiation chamber to photoactivation patient treatment system
US4897789A (en) * 1986-02-27 1990-01-30 Mcneilab, Inc. Electronic device for authenticating and verifying disposable elements
USD299531S (en) * 1986-02-27 1989-01-24 Mcneilab, Inc. Patient photopheresis treatment unit
USD298279S (en) * 1986-02-27 1988-10-25 Mcneilab, Inc. Disposable patient fluid irradiation chamber
USD298567S (en) * 1986-02-27 1988-11-15 Mcneilab, Inc. Flexible patient fluid container
USD299953S (en) * 1986-02-27 1989-02-21 Mcneilab, Inc. Control panel for a patient photophoresis treatment unit
US4726949A (en) * 1986-08-26 1988-02-23 Baxter Travenol Laboratories, Inc. Irradiation of blood products
US4866282A (en) * 1986-08-26 1989-09-12 Baxter International Inc. Irradiation of blood products
US4952812A (en) * 1986-08-26 1990-08-28 Baxter International Inc. Irradiation of blood products
US4838852A (en) * 1987-03-27 1989-06-13 Therakos, Inc. Active specific immune suppression
US4878891A (en) * 1987-06-25 1989-11-07 Baylor Research Foundation Method for eradicating infectious biological contaminants in body tissues
US4960408A (en) * 1989-01-10 1990-10-02 Klainer Albert S Treatment methods and vaccines for stimulating an immunological response against retroviruses
US5356929A (en) * 1989-01-23 1994-10-18 Lehigh University Reduced and quaternized psoralens as photo-activated therapeutics
US5216176A (en) * 1989-01-23 1993-06-01 Lehigh University 7-alkoxycoumarins, dihydropsoralens, and benzodipyranones as photo-activated therapeutic agents and inhibitors of epidermal growth factor
US4921473A (en) * 1989-02-02 1990-05-01 Therakos, Inc. Multicomponent fluid separation and irradiation system
US4999375A (en) * 1989-04-11 1991-03-12 Hoffmann-La Roche Inc. Psoralen reagent compositions for extracorporeal treatment of blood
ES2110002T3 (es) * 1991-06-21 1998-02-01 Baxter Int Procedimiento de inactivacion de agentes patogenos en fluidos corporales.
AU3476593A (en) * 1992-01-27 1993-09-01 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
US5288605A (en) * 1992-03-02 1994-02-22 Steritech, Inc. Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
US5459030A (en) * 1992-03-02 1995-10-17 Steritech, Inc. Synthetic media compositions for inactivating bacteria and viruses in blood preparations with 8-methoxypsoralen
CA2141803C (en) * 1992-08-07 2003-06-17 Lily Lin Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
US5820872A (en) * 1992-11-18 1998-10-13 Yale University Methods and compositions for improving the effectiveness of X-irradiation therapy for the treatment of an internal solid tumor
US5651993A (en) * 1992-11-18 1997-07-29 Yale University Specific immune system modulation
US5399719A (en) * 1993-06-28 1995-03-21 Steritech, Inc. Compounds for the photodecontamination of pathogens in blood
AU6267596A (en) * 1995-12-14 1997-07-03 Steritech, Inc. Inactivation of non-enveloped virus
IL126365A0 (en) * 1996-03-29 1999-05-09 Therakos Inc Photopheresis treatment of chronic hcv infections
WO1997037654A1 (en) * 1996-04-10 1997-10-16 The Trustees Of The University Of Pennsylvania Use of photopheresis in the treatment of chronic infection by hepatitis c virus

Also Published As

Publication number Publication date
ATE300298T1 (de) 2005-08-15
IL126366A (en) 2011-10-31
IL126366A0 (en) 1999-05-09
AU2422897A (en) 1997-10-22
EP0935462B1 (en) 2005-07-27
EP0935462A1 (en) 1999-08-18
CA2250919A1 (en) 1997-10-09
CN1121217C (zh) 2003-09-17
DE69733826D1 (de) 2005-09-01
CA2250919C (en) 2008-05-13
US5984887A (en) 1999-11-16
EP0935462A4 (en) 2001-04-18
WO1997036581A1 (en) 1997-10-09
CN1214630A (zh) 1999-04-21
AU710242B2 (en) 1999-09-16
JP2000510101A (ja) 2000-08-08
DE69733826T2 (de) 2006-05-24

Similar Documents

Publication Publication Date Title
BR9708468A (pt) Tratamento de fotoferese de leucocitos.
ES2102860T3 (es) Tratamiento cosmetico de substratos.
FI952701A0 (fi) Metallisen kirurgisen istukkaan käsittelymenetelmä
RU94041950A (ru) Использование соединений ряда 3-аролоксипропиламинов в лечении недержания
DE69528751D1 (de) Verwendung von Interferon-alpha 8 subtype zur Herstellung von Medikamenten zur Behandlung von Viralinfektionen der Leber
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
ATE282425T1 (de) Verfahren zur behandlung von endothelialen verletzungen
UA49869C2 (uk) Нафтил-заміщені похідні бензимідазолу, фармацевтична композиція, спосіб лікування (варіанти) та спосіб інгібування людського фактора
BR9708114A (pt) Análogos xantona para o tratamento de doenças infecciosas.
ES2153851T3 (es) Tratamiento de la atrofia de la piel y de la vagina.
BR9708406A (pt) Tratamento por fotoferese de infecções crÈnicas por hcv.
DE69834724D1 (de) Behandlung von Darm- oder Blasenentzündungen
BR0007448A (pt) Uso de um inibidor de trombina de baixo peso molecular, solução de diálise, concentrado de diálise, kit de partes para uso em diálise, processo para a preparação de uma solução, ou de um concentrado, e, método de tratamento por diálise de um paciente necessitando de tal tratamento
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
BR0016163A (pt) Tratamento de infecções virais que usa levovirin(r)
DE10299005I1 (de) Verwendung von 1-Beta-D-ribofuranosyl-1,2,4-triazol-3-carboxamid (Ribavirin) zur Herstellung eines Medikaments fuer die Behandlung von Arboviren
BR0012921A (pt) Compostos calcilìticos
DE69838980D1 (de) Kombination von product r mit einem antiviralen mittel in der behandlung von hiv infektionen
GR3033698T3 (en) Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections.
ATE225181T1 (de) Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen
BR9914570A (pt) Processo para o tratamento da esquizofrenia bem como agentes para o emprego neste processo
DE69810724D1 (de) Verwendung von Protein C Inhibitor zur Behandlung disseminierter intravasaler Gerinnung (DIC)
DK664188D0 (da) Butylhydroxyanisoler til behandling af retrovirale sygdomme
ATE222103T1 (de) Inklusionskomplexe in waessriger loesung
ATE245199T1 (de) Behandlung von influenzavirus-infektion unter verwendung von antiviralen acylierung/palmitylierung von hemagglutinin hemmen

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal